Standard BioTools Inc. Other Comprehensive Income (Loss), Net of Tax
Standard BioTools Inc. (LAB) reported Other Comprehensive Income (Loss), Net of Tax of $186.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2018-03-08
- Standard BioTools Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-06-30 was $27.00K.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-03-31 was $259.00K, a 33.51% increase year-over-year.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for the quarter ending 2015-12-31 was -$350.00K, a 4475.00% decline year-over-year.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for the quarter ending 2015-09-30 was -$97.00K.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for fiscal 2017 was $186.00K, a 51.56% decline from fiscal 2016.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for fiscal 2016 was $384.00K.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for fiscal 2015 was -$350.00K.
- Standard BioTools Inc. other comprehensive income (loss), net of tax for fiscal 2014 was -$64.00K, a 264.10% decline from fiscal 2013.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2017-12-31 | $186.00K 10-K · filed 2018-03-08 | |||
| 2016-12-31 | $384.00K 10-K · filed 2018-03-08 | |||
| 2016-06-30 | $27.00K 10-Q · filed 2016-08-09 | $286.00K 10-Q · filed 2016-08-09 | -$64.00K derived: sum of 3 quarters · filed 2018-03-08 | -$161.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $259.00K 10-Q · filed 2016-05-09 | -$91.00K derived: sum of 2 quarters · filed 2018-03-08 | -$188.00K derived: sum of 3 quarters · filed 2018-03-08 | -$285.00K derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$447.00K derived: sum of 2 quarters · filed 2018-03-08 | -$544.00K derived: sum of 3 quarters · filed 2018-03-08 | -$350.00K 10-K · filed 2018-03-08 |
| 2015-09-30 | -$97.00K 10-Q · filed 2015-11-09 | -$194.00K derived: sum of 2 quarters · filed 2016-08-09 | $0.00 10-Q · filed 2015-11-09 | $8.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | -$97.00K 10-Q · filed 2016-08-09 | $97.00K 10-Q · filed 2016-08-09 | $105.00K derived: sum of 3 quarters · filed 2017-03-03 | $3.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $194.00K 10-Q · filed 2016-05-09 | $202.00K derived: sum of 2 quarters · filed 2017-03-03 | $100.00K derived: sum of 3 quarters · filed 2017-03-03 | $157.00K derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$94.00K derived: sum of 2 quarters · filed 2017-03-03 | -$37.00K derived: sum of 3 quarters · filed 2017-03-03 | -$64.00K 10-K · filed 2017-03-03 |
| 2014-09-30 | -$102.00K 10-Q · filed 2015-11-09 | -$45.00K derived: sum of 2 quarters · filed 2015-11-09 | -$72.00K 10-Q · filed 2015-11-09 | -$90.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $57.00K 10-Q · filed 2015-08-10 | $30.00K 10-Q · filed 2015-08-10 | $12.00K derived: sum of 3 quarters · filed 2016-02-29 | $94.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$28.00K 10-Q · filed 2015-05-11 | -$45.00K derived: sum of 2 quarters · filed 2016-02-29 | $37.00K derived: sum of 3 quarters · filed 2016-02-29 | $14.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $65.00K derived: sum of 2 quarters · filed 2016-02-29 | $42.00K derived: sum of 3 quarters · filed 2016-02-29 | $39.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $82.00K 10-Q · filed 2014-11-06 | $59.00K derived: sum of 2 quarters · filed 2014-11-06 | $56.00K 10-Q · filed 2014-11-06 | $60.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$23.00K 10-Q · filed 2014-08-04 | -$26.00K 10-Q · filed 2014-08-04 | -$22.00K derived: sum of 3 quarters · filed 2015-02-26 | -$14.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$4.00K 10-Q · filed 2014-05-12 | $1.00K derived: sum of 2 quarters · filed 2015-02-26 | $9.00K derived: sum of 3 quarters · filed 2015-02-26 | $5.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $13.00K derived: sum of 2 quarters · filed 2015-02-26 | $9.00K derived: sum of 3 quarters · filed 2015-02-26 | -$15.00K 10-K · filed 2015-02-26 |
| 2012-09-30 | $8.00K 10-Q · filed 2013-11-07 | $4.00K derived: sum of 2 quarters · filed 2013-11-07 | -$20.00K 10-Q · filed 2013-11-07 | |
| 2012-06-30 | -$4.00K 10-Q · filed 2013-08-07 | -$28.00K 10-Q · filed 2013-08-07 | ||
| 2012-03-31 | -$23.00K 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | $24.00K 10-K · filed 2014-03-12 | |||
| 2010-12-31 | -$274.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |